RENX
Renalytix
UK company
Healthcare
Diagnostics & Research
/
Bid
-
Ask
-
Last Traded
-
Chg
-
-
XLON
-
Updated: -
Research
News & analysis
Regulatory news
Times are shown in BST, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
/
Company Profile
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Loading Comparison
Latest RENX News
RENX Regulatory News